Latest Market Reaction News

Regener8 Resources has addressed a sharp doubling in its share price, attributing the surge to growing market interest in its North Achilles project amid soaring silver prices and nearby discoveries.

BlackRock Investment Management (Australia) Limited has announced final cash distributions for 14 Australian domiciled iShares ETFs, with payments scheduled for 22 October 2025. Investors are reminded of key dates and tax certification requirements under FATCA and CRS.

VHM Limited has clarified that a non-binding US$200 million letter of interest from the US Export-Import Bank for its Goschen project is not material to its share price, confirming full compliance with ASX disclosure rules despite recent market speculation.

Ardiden Ltd’s trading suspension has been lifted following its announcement of a significant gold acquisition and a capital raising initiative, signaling a pivotal moment for the company’s growth strategy.

Vonex Limited’s shares will be suspended from ASX trading following court approval of its acquisition by Maxo Telecommunications, marking a pivotal moment for the telecom services company.

Pathkey.AI’s TrialKey platform continues to validate its AI-driven clinical trial success predictions, with September 2025 seeing an average 43.6% share price increase across flagged biotech stocks.

Seafarms Group Limited has resumed trading on the ASX following the lifting of its suspension, triggered by the lodgement of its annual financial report.

Felix Gold Limited confirmed the materiality of a senior US federal officials' visit to its Treasure Creek Antimony Project, explaining the delayed disclosure was due to legal restrictions imposed by US authorities. The company affirmed compliance with ASX continuous disclosure rules following the announcement.

Nelson Resources has confirmed it is in confidential negotiations for a Right to Mine contract, explaining recent unusual trading activity in its shares. The company maintains compliance with ASX disclosure rules while awaiting contract finalisation.

Myer Holdings has clarified that its FY2025 earnings aligned with market forecasts, addressing concerns following a sharp share price drop after its results announcement.

Bio-Gene Technology Limited has addressed ASX concerns over the timing of its announcement on promising Flavocide efficacy data, confirming compliance with continuous disclosure rules after receiving final presentation materials from Purdue University.

Aguia Resources has responded to an ASX price query following a dramatic surge in its share price, confirming no new material exploration results have been received or withheld. The company asserts full compliance with continuous disclosure obligations despite market speculation.